Partner
Evan Rachlin, MD
Co-Founder and Managing Partner, Ascenta Capital
- Firm
- Ascenta Capital
- Title
- Co-Founder and Managing Partner
- Role
- Managing partner
- Known as
- Investor
Record updated 28 September 2026
About
Evan Rachlin, MD, is the co-founder and a Managing Partner of Ascenta Capital, which he co-leads with Lorence Kim. Evan was previously a Managing Director at Blackstone Life Sciences from 2019 to 2022. Prior to Blackstone, he was Head of Strategy (reporting to the CEO) at Moderna (NASDAQ: MRNA) from 2015 to 2019, where he led development of the company's annual long-range plan and helped formulate portfolio strategy and execute equity financings. He was a Principal at Bain Capital Ventures from 2012 to 2015, and began his career in New York City at McKinsey & Company and Pfizer. In addition to his Ascenta boards, Evan serves on the board of Boston Children's Hospital Trust. Evan graduated from Harvard University, magna cum laude with an A.B. in Biochemistry and Japanese. He earned an M.D. from Harvard Medical School.
Is this you? Remove my profile